EUVIMEDEUVIMED entdecken
Fall-Kontroll-Studie

COVID-19 infection and risk of incident hypertension: a case-control time-to-event study

Jeremy David Goldhaber-Fiebert iD, Shannon C Phillips iD, Kimberley D Lucas iD, Donna A Jacobsen, David Studdert iD

American Journal of Epidemiology · 2025

DOI: 10.1093/aje/kwaf283 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift American Journal of Epidemiology, 2025. Verfasst von Jeremy David Goldhaber-Fiebert und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Policy, Stanford Medical School, Stanford University, Stanford, CA 94305 United States. Hauptthemen laut MEDLINE: COVID-19, Hypertension. Die Arbeit nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Most previous studies of increased hypertension (HTN) incidence following COVID-19 infection lack longitudinal testing and diagnostic information and under-represent minorities. We examined this relationship using a case–control time-to-event-study of 39 746 individuals continuously incarcerated from January 1, 2019, to March 1, 2020 (pandemic start), followed until March 1, 2023 in 31 California state prisons. Those included had no pre-pandemic HTN diagnosis and no blood pressure-altering medication prescriptions; had body mass index (BMI) and blood pressure measurements before and during the pandemic; and were tested for COVID-19. Exposure began 31 days after COVID-19 positivity. Clinical diagnosis established incident HTN. Multivariate Cox proportional hazards models adjusted for age, sex, race/ethnicity, BMI, baseline blood pressure, and frequency of healthcare contacts and COVID-19 testing. We assessed confounding from changes in HTN testing post-COVID. 21 480 individuals tested COVID-19 positive prior to HTN diagnosis (or censoring). The subsequent crude HTN incidence rate was 32.5 per 1000 person-years (exposed) [95%CI, 30.5-34.6] versus 27.1 (unexposed) [25.8-28.5]. COVID-19 infection was associated with significantly increased HTN incidence (main effects HRR, 1.44 [1.32-1.57]; including interactions: HRR, 2.05 [1.50-2.79]), with stronger association for higher BMI, higher pre-pandemic blood pressure, and older age. Potential confounding from post-COVID increases in HTN diagnostic testing cannot explain these results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HypertensionHumansFemaleMaleCase-Control StudiesMiddle AgedIncidenceAdultCaliforniaRisk FactorsSARS-CoV-2Proportional Hazards ModelsBody Mass IndexAged

Stichwörter der Autor:innen

COVID-19SARS-CoV-2high blood pressurehypertensionincidencerisk factor

Autor:innen und Institutionen

  • Department of Health Policy, Stanford Medical School, Stanford University, Stanford, CA 94305 United States.
  • Center for Health Policy, Freeman Spogli Institute, Stanford University, Stanford, CA 94305 United States.
  • California Correctional Health Care Services, Elk Grove, CA 95758, United States.
  • Stanford Law School, Stanford University, Stanford, CA 94305, United States.

ORCID-Profile: Jeremy David Goldhaber-Fiebert, Shannon C Phillips, Kimberley D Lucas, David Studdert

Zitieren

APA

Goldhaber-Fiebert, J. D., Phillips, S. C., Lucas, K. D., Jacobsen, D. A., & Studdert, D. (2025). COVID-19 infection and risk of incident hypertension: a case-control time-to-event study. American Journal of Epidemiology. https://doi.org/10.1093/aje/kwaf283

Vancouver

Goldhaber-Fiebert JD, Phillips SC, Lucas KD, Jacobsen DA, Studdert D. COVID-19 infection and risk of incident hypertension: a case-control time-to-event study. American Journal of Epidemiology. 2025. doi:10.1093/aje/kwaf283

BibTeX
@article{GoldhaberFiebert2025,
  author = {Goldhaber-Fiebert, Jeremy David and Phillips, Shannon C and Lucas, Kimberley D and Jacobsen, Donna A and Studdert, David},
  title = {COVID-19 infection and risk of incident hypertension: a case-control time-to-event study},
  journal = {American Journal of Epidemiology},
  year = {2025},
  doi = {10.1093/aje/kwaf283}
}
Kostenlos starten →